Diagnostic value of anti-terminal deoxynucleotidyl transferase antibody (TdT) in hematologic pathology;Intérêt diagnostique de l'anticorps anti-terminal désoxynucleotidyl transférase (TdT) en pathologie hématologique

Annales de Pathologie

Volumn 25, Issue 1, 2005, Pages 25-32

  Valmary, Séverine ^a   Danjoux, Marie ^a   Delsol, Georges ^a   Brousset, Pierre ^a  

^a CHU PURPAN   (France)

Author keywords

Acute lymphoblastic lymphoma; Lymphoblastic lymphoma; TdT

Indexed keywords

ENZYME ANTIBODY; MONOCLONAL ANTIBODY; TERMINAL DEOXYNUCLEOTIDYLTRANSFERASE ANTIBODY; TUMOR MARKER; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE MONOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; B ACUTE LYMPHOBLASTIC LEUKEMIA; B LYMPHOBLASTIC LYMPHOMA; BURKITT LYMPHOMA; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ERROR; DIAGNOSTIC VALUE; FEMALE; HEMATOLOGIC MALIGNANCY; HEMATOLOGIC PATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LYMPHOBLAST; LYMPHOBLASTOMA; LYMPHOMA; MALE; PATHOLOGY; PROTEIN EXPRESSION; SCHOOL CHILD; STATISTICAL SIGNIFICANCE; T ACUTE LYMPHOBLASTIC LEUKEMIA; T LYMPHOBLASTIC LYMPHOMA;

EID: 16844373887     PISSN: 02426498     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0242-6498(05)80096-3     Document Type: Article

References (22)

1. Quintanilla-Martinez L, Zukerberg LR, Ferry JA, Harris NL. Extramedullary tumors of lymphoid or myeloid blasts. The role of immunohistology in diagnosis and classification. Am J Clin Pathol 1995; 104: 431-43.
2. Brunning RD, Borowitz M, Matutes E, Head D, Flandrin G, Swerdlow et al. Precursor B/T lymphoblastic leukaemia / lymphoblastic lymphoma. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. Tumours of Haematopoietic and lymphoid tissues. IARC Press, Lyon 2001.
3. Cossman J, Chused TM, Fisher RI, Magrath I, Bollum F, Jaffe ES. Diversity of immunological phenotypes of lymphoblastic lymphoma. Cancer Res 1983; 79:387-91.
4. Koita H, Suzumiya J, Ohshima K, Takeshita M, Kimura N, Kikuchi M et al. Lymphoblastic lymphoma expressing natural killer cell phenotype with involvement of the mediastinum and nasal cavity. Am J Surg Pathol 1997; 21: 242-8.
5. Nakamura S, Koshikawa T, Yatabe Y, Suchi T. Lymphoblastic lymphoma expressing CD56 and TdT. Am J Surg Pathol 1998; 22: 135-7.
6. Weiss L, Bindl J, Picozzi V, Link M, Warnke R. Lymphoblastic lymphoma: an immunophenotype study of 26 cases with comparison to T-cell acute lymphoblastic leukemia. Blood 1986; 67: 474-81.
7. VanDongen J, Krissansen G, Wolvers-Tettero I. Cytoplasmic expression of the CD3 antigen as a diagnostic marker for immature T-cell malignancies. Blood 1988; 71: 603-12.
8. Uckun FM. Regulation of human B-cell ontogeny. Blood 1990; 76: 1908-23.
9. Maitra A, McKenna RW, Weinberg AG, Schneider NR, Kroft SH. Precursor B-cell lymphoblastic lymphoma. A study of nine cases lacking blood and bone marrow involvement and review of the literature. Am J Clin Pathol 2001; 115: 868-75.
10. Mc Caffrey R, Harrison TA, Parkman R, Baltimore D: Terminal deoxynucleotidyl transferase activity in human leukemic cells and in normal thymocytes. N Engl J Med 1975; 292: 775-80.
11. Orazi A, Cattoretti G, John K, Neiman RS. Terminal deoxynucleotidyl transferase staining of malignant lymphomas in paraffin sections. Mod Pathol 1994; 7: 582-6.
12. Orazi A, Cotton J, Cattoretti G, Kotylo PK, John K, Manning JT et al. Terminal deoxynucleotidyl transferase staining in acute leukemia and normal bone marrow in routinely processed paraffin sections. Am J Clin Pathol 1994; 102: 640-5.
13. Faber J, Kantarjian H, Roberts MW, Keating M, Freireich E, Albitar M. Terminal deoxynucleotidyl transferase-negative acute lymphoblastic leukemia. Arch Pathol Lab Med 2000; 124: 92-7.
14. Suzumiya J, Ohshima K, Kikuchi M, Takeshita M, Akamatsu M, Tashiro K. Terminal deoxynucleotidyl transferase staining of malignant lymphomas in paraffin sections: a useful method for the diagnosis of lymphoblastic lymphoma. J Pathol 1997; 182: 86-91.
15. Long J, McCaffrey R, Aisenberg A, Marks S, Kung P. Terminal deoxynucleotidyl transferase positive lymphoblastic lymphoma. Cancer 1979; 44: 2127-39.
16. Brousset P, Imadalou K, Rubie H, Delsol-Tahou M, Selves J, Robert A et al. Paraffin-section immunohistochemistry of residual disease in the testis in patients with acute lymphoblastic leukemia using anti-mb-1/CD79a (JCBI17) monoclonal antibody. Appl Immunohistochem 1996; 4: 56-60.
17. Mason DY, Cordell JL, Brown MH, Borst J, Jones M, Pulford K et al. CD79a: a novel marker for B-cell neoplasms in routinely processed tissue samples. Blood 1995; 86: 1453-9.
18. Khoury JD, Medeiros LJ, Manning JT, Sulak LE, Bueso-Ramos C, Jones D. CD56 (+) TdT (+) blastic natural killer cell tumor of the skin: a primitive systemic malignancy related to myelomonocytic leukemia. Cancer 2002; 94: 2401-8.
19. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C. Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group. Br J Haematol 1976; 33: 451-8.
20. Ozdemirli M, Fanburg-Smith JC, Hartmann DP, Shad AT, Lage JM, Magrath IT et al. Precursor B-lymphoblastic lymphoma presenting as a solitary bone tumor and mimicking Ewing's sarcoma. Am J Surg Pathol 1998; 22: 795-804.
21. MacCurley TL, Greer JP, Glick AD. Terminal deoxynucleotidyl transferase (TdT) in acute nonlymphocytic leukemia: a clinical morphological, cytochemical, immunologic, and ultrastructural study. Am J Clin Pathol 1988; 90: 421-30.
22. Soslow RA, Bhargava V, Warnke RA. MIC2, TdT, bcl-2, and CD34 expression in paraffin-embedded high-grade lymphoma/acute lymphoblastic leukemia distinguishes between distinct clinicopathologic entities. Hum Pathol 1997; 28: 1158-65.